HealthInvest Partners AB Activity Q4 2006-Q4 2022

Q4 2022

			Value		Shares		↓ Weighting
UTMD	Buy	UTAH MED PRODS INC	$9,449,820	+28.8%	94,000	+9.3%	18.25%	+17.7%
CAH	Buy	CARDINAL HEALTH INC	$7,687,000	+64.7%	100,000	+42.9%	14.84%	+50.5%
CI	Sell	CIGNA CORP NEW	$5,301,440	+12.4%	16,000	-5.9%	10.24%	+2.7%
VTRS	Sell	VIATRIS INC	$5,286,750	+29.3%	475,000	-1.0%	10.21%	+18.2%
	New	GSK PLCsponsored adr	$5,271,000	–	150,000	–	10.18%	–
GILD	Sell	GILEAD SCIENCES INC	$5,216,246	-19.5%	60,760	-42.1%	10.07%	-26.4%
CVS	New	CVS HEALTH CORP	$4,845,880	–	52,000	–	9.36%	–
BMY	Sell	BRISTOL-MYERS SQUIBB CO	$4,676,750	-32.9%	65,000	-33.7%	9.03%	-38.6%
KMPH	Sell	KEMPHARM INC	$1,514,700	-67.6%	330,000	-56.0%	2.92%	-70.4%
UNH	New	UNITEDHEALTH GROUP INC	$200,938	–	379	–	0.39%	–
ABBV	New	ABBVIE INC	$131,066	–	811	–	0.25%	–
MRK	New	MERCK & CO INC	$123,155	–	1,110	–	0.24%	–
LLY	New	LILLY ELI & CO	$122,556	–	335	–	0.24%	–
TMO	New	THERMO FISHER SCIENTIFIC INC	$121,152	–	220	–	0.23%	–
REGN	New	REGENERON PHARMACEUTICALS	$67,099	–	93	–	0.13%	–
PFE	New	PFIZER INC	$62,513	–	1,220	–	0.12%	–
VRTX	New	VERTEX PHARMACEUTICALS INC	$62,376	–	216	–	0.12%	–
ABC	New	AMERISOURCEBERGEN CORP	$51,204	–	309	–	0.10%	–
BSX	New	BOSTON SCIENTIFIC CORP	$49,092	–	1,061	–	0.10%	–
SYK	New	STRYKER CORPORATION	$48,409	–	198	–	0.09%	–
IQV	New	IQVIA HLDGS INC	$44,051	–	215	–	0.08%	–
BMRN	New	BIOMARIN PHARMACEUTICAL INC	$42,845	–	414	–	0.08%	–
MRNA	New	MODERNA INC	$33,589	–	187	–	0.06%	–
DXCM	New	DEXCOM INC	$33,859	–	299	–	0.06%	–
RPRX	New	ROYALTY PHARMA PLC	$31,260	–	791	–	0.06%	–
EW	New	EDWARDS LIFESCIENCES CORP	$26,561	–	356	–	0.05%	–
OPCH	New	OPTION CARE HEALTH INC	$22,146	–	736	–	0.04%	–
MASI	New	MASIMO CORP	$22,488	–	152	–	0.04%	–
ALNY	New	ALNYLAM PHARMACEUTICALS INC	$22,101	–	93	–	0.04%	–
NBIX	New	NEUROCRINE BIOSCIENCES INC	$22,216	–	186	–	0.04%	–
CYTK	New	CYTOKINETICS INC	$20,161	–	440	–	0.04%	–
ITCI	New	INTRA-CELLULAR THERAPIES INC	$15,453	–	292	–	0.03%	–
DOCS	New	DOXIMITY INCcl a	$15,505	–	462	–	0.03%	–
EXAS	New	EXACT SCIENCES CORP	$13,269	–	268	–	0.03%	–
RXDX	New	PROMETHEUS BIOSCIENCES INC	$13,420	–	122	–	0.03%	–
INSP	New	INSPIRE MED SYS INC	$13,098	–	52	–	0.02%	–
KRYS	New	KRYSTAL BIOTECH INC	$11,012	–	139	–	0.02%	–
AKRO	New	AKERO THERAPEUTICS INC	$9,097	–	166	–	0.02%	–
BLU	New	BELLUS HEALTH INC NEW	$8,837	–	1,075	–	0.02%	–
OM	New	OUTSET MED INC	$8,882	–	344	–	0.02%	–
PRTA	New	PROTHENA CORP PLC	$7,893	–	131	–	0.02%	–
FOLD	New	AMICUS THERAPEUTICS INC	$6,764	–	554	–	0.01%	–
SWAV	New	SHOCKWAVE MED INC	$6,580	–	32	–	0.01%	–
MRVI	New	MARAVAI LIFESCIENCES HLDGS I	$6,797	–	475	–	0.01%	–
KRTX	New	KARUNA THERAPEUTICS INC	$6,681	–	34	–	0.01%	–
BBIO	New	BRIDGEBIO PHARMA INC	$6,759	–	887	–	0.01%	–
BCYC	New	BICYCLE THERAPEUTICS PLCsponsored adr	$6,690	–	226	–	0.01%	–
IMGN	New	IMUNOGEN INC	$6,448	–	1,300	–	0.01%	–
PSTX	New	POSEIDA THERAPEUTICS INC	$5,666	–	1,069	–	0.01%	–
MRUS	New	MERUS N V	$4,424	–	286	–	0.01%	–
	New	ARCELLX INC	$4,399	–	142	–	0.01%	–
DNLI	New	DENALI THERAPEUTICS INC	$4,394	–	158	–	0.01%	–
OPNT	Exit	OPIANT PHARMACEUTICALS INC	$0	–	-210,000	–	-4.77%	–
MCK	Exit	MCKESSON CORP	$0	–	-13,000	–	-9.33%	–

Q3 2022

			Value		Shares		↓ Weighting
BMY	Buy	BRISTOL-MYERS SQUIBB CO	$6,967,000	+105.6%	98,000	+122.7%	14.72%	+88.4%
GILD	Buy	GILEAD SCIENCES INC	$6,477,000	+80.7%	105,000	+81.0%	13.68%	+65.5%
CI	Buy	CIGNA CORP NEW	$4,717,000	+27.9%	17,000	+21.4%	9.96%	+17.2%
KMPH	Buy	KEMPHARM INC	$4,680,000	+56.6%	750,000	+11.9%	9.89%	+43.5%
CAH	New	CARDINAL HEALTH INC	$4,668,000	–	70,000	–	9.86%	–
MCK	Buy	MCKESSON CORP	$4,418,000	+35.4%	13,000	+30.0%	9.33%	+24.1%
VTRS	Buy	VIATRIS INC	$4,090,000	+26.0%	480,000	+54.8%	8.64%	+15.4%
BIIB	Exit	BIOGEN INC	$0	–	-16,000	–	-7.52%	–
HRMY	Exit	HARMONY BIOSCIENCES HLDGS IN	$0	–	-76,000	–	-8.54%	–
LJPC	Exit	LA JOLLA PHARMACEUTICAL CO	$0	–	-1,265,000	–	-9.30%	–

Q2 2022

			Value		Shares		↓ Weighting
UTMD	New	UTAH MED PRODS INC	$7,387,000	–	86,000	–	17.03%	–
LJPC	New	LA JOLLA PHARMACEUTICAL CO	$4,035,000	–	1,265,000	–	9.30%	–
HRMY	New	HARMONY BIOSCIENCES HLDGS IN	$3,707,000	–	76,000	–	8.54%	–
CI	New	CIGNA CORP NEW	$3,689,000	–	14,000	–	8.50%	–
GILD	New	GILEAD SCIENCES INC	$3,585,000	–	58,000	–	8.26%	–
BMY	New	BRISTOL-MYERS SQUIBB CO	$3,388,000	–	44,000	–	7.81%	–
BIIB	New	BIOGEN INC	$3,263,000	–	16,000	–	7.52%	–
MCK	New	MCKESSON CORP	$3,262,000	–	10,000	–	7.52%	–
VTRS	New	VIATRIS INC	$3,246,000	–	310,000	–	7.48%	–
KMPH	New	KEMPHARM INC	$2,988,000	–	670,000	–	6.89%	–
OPNT	New	OPIANT PHARMACEUTICALS INC	$2,518,000	–	210,000	–	5.80%	–
AUPH	New	AURINIA PHARMACEUTICALS INC	$2,312,000	–	230,000	–	5.33%	–

Q4 2021

			Value		Shares		↓ Weighting
LJPC	Exit	LA JOLLA PHARMACEUTICAL CO	$0	–	-270,000	–	-1.61%	–
URGN	Exit	UROGEN PHARMA LTD	$0	–	-75,000	–	-1.89%	–
CAH	Exit	CARDINAL HEALTH INC	$0	–	-32,000	–	-2.37%	–
MCK	Exit	MCKESSON CORP	$0	–	-8,000	–	-2.39%	–
ABBV	Exit	ABBVIE INC	$0	–	-15,000	–	-2.42%	–
BMY	Exit	BRISTOL-MYERS SQUIBB CO	$0	–	-28,000	–	-2.48%	–
ABC	Exit	AMERISOURCEBERGEN CORP	$0	–	-14,000	–	-2.50%	–
EOLS	Exit	EVOLUS INC	$0	–	-300,000	–	-3.42%	–
ALDX	Exit	ALDEYRA THERAPEUTICS INC	$0	–	-310,000	–	-4.08%	–
ZGNX	Exit	ZOGENIX INC	$0	–	-220,000	–	-5.01%	–
UTMD	Exit	UTAH MED PRODS INC	$0	–	-42,000	–	-5.84%	–
LCI	Exit	LANNET INC	$0	–	-1,775,000	–	-7.98%	–
RIGL	Exit	RIGEL PHARMACEUTICALS INC	$0	–	-1,765,000	–	-9.60%	–
HRMY	Exit	HARMONY BIOSCIENCES HLDGS IN	$0	–	-185,000	–	-10.62%	–
ARAY	Exit	ACCURAY INC	$0	–	-1,860,000	–	-11.00%	–
SUPN	Exit	SUPERNUS PHARMACEUTICALS INC	$0	–	-335,000	–	-13.38%	–
IRWD	Exit	IRONWOOD PHARMACEUTICALS INC	$0	–	-685,000	–	-13.40%	–

Q3 2021

			Value		Shares		↓ Weighting
IRWD	Sell	IRONWOOD PHARMACEUTICALS INC	$8,946,000	-54.3%	685,000	-54.9%	13.40%	-27.7%
SUPN	Sell	SUPERNUS PHARMACEUTICALS INC	$8,934,000	-45.3%	335,000	-36.8%	13.38%	-13.5%
ARAY	Sell	ACCURAY INC	$7,347,000	-29.3%	1,860,000	-19.1%	11.00%	+11.7%
HRMY	New	HARMONY BIOSCIENCES HLDGS IN	$7,091,000	–	185,000	–	10.62%	–
RIGL	New	RIGEL PHARMACEUTICALS INC	$6,407,000	–	1,765,000	–	9.60%	–
LCI	New	LANNET INC	$5,325,000	–	1,775,000	–	7.98%	–
UTMD	New	UTAH MED PRODS INC	$3,899,000	–	42,000	–	5.84%	–
ZGNX	New	ZOGENIX INC	$3,342,000	–	220,000	–	5.01%	–
ALDX	New	ALDEYRA THERAPEUTICS INC	$2,722,000	–	310,000	–	4.08%	–
EOLS	New	EVOLUS INC	$2,286,000	–	300,000	–	3.42%	–
ABC	New	AMERISOURCEBERGEN CORP	$1,672,000	–	14,000	–	2.50%	–
BMY	Sell	BRISTOL-MYERS SQUIBB CO	$1,657,000	-83.1%	28,000	-81.0%	2.48%	-73.3%
ABBV	Sell	ABBVIE INC	$1,618,000	-83.1%	15,000	-82.4%	2.42%	-73.3%
MCK	Sell	MCKESSON CORP	$1,595,000	-84.0%	8,000	-84.6%	2.39%	-74.6%
CAH	Sell	CARDINAL HEALTH INC	$1,583,000	-83.7%	32,000	-81.2%	2.37%	-74.2%
URGN	New	UROGEN PHARMA LTD	$1,262,000	–	75,000	–	1.89%	–
LJPC	New	LA JOLLA PHARMACEUTICAL CO	$1,077,000	–	270,000	–	1.61%	–
CI	Exit	CIGNA CORP NEW	$0	–	-41,000	–	-9.21%	–
VRTX	Exit	VERTEX PHARMACEUTICALS INC	$0	–	-52,000	–	-9.94%	–

Q2 2021

			Value		Shares		↓ Weighting
IRWD	New	IRONWOOD PHARMACEUTICALS INC	$19,562,000	–	1,520,000	–	18.54%	–
SUPN	New	SUPERNUS PHARMACEUTICALS INC	$16,319,000	–	530,000	–	15.46%	–
VRTX	New	VERTEX PHARMACEUTICALS INC	$10,485,000	–	52,000	–	9.94%	–
ARAY	New	ACCURAY INC	$10,396,000	–	2,300,000	–	9.85%	–
MCK	New	MCKESSON CORP	$9,944,000	–	52,000	–	9.42%	–
BMY	New	BRISTOL-MYERS SQUIBB CO	$9,823,000	–	147,000	–	9.31%	–
CI	New	CIGNA CORP NEW	$9,720,000	–	41,000	–	9.21%	–
CAH	New	CARDINAL HEALTH INC	$9,705,000	–	170,000	–	9.20%	–
ABBV	New	ABBVIE INC	$9,574,000	–	85,000	–	9.07%	–

Q4 2017

			Value		Shares		↓ Weighting
GILD	Exit	GILEAD SCIENCES INC	$0	–	-76,600	–	-7.25%	–
MDT	Exit	MEDTRONIC PLC	$0	–	-82,100	–	-7.46%	–
LH	Exit	LABORATORY CORP AMER HLDGS	$0	–	-42,300	–	-7.46%	–
BIIB	Exit	BIOGEN INC	$0	–	-20,400	–	-7.46%	–
WAT	Exit	WATERS CORP	$0	–	-35,900	–	-7.53%	–
PFE	Exit	PFIZER INC	$0	–	-181,300	–	-7.56%	–
LGND	Exit	LIGAND PHARMACEUTICALS INC	$0	–	-47,900	–	-7.62%	–
CRL	Exit	CHARLES RIV LABS INTL INC	$0	–	-60,812	–	-7.67%	–
CI	Exit	CIGNA CORPORATION	$0	–	-35,200	–	-7.68%	–
ANIK	Exit	ANIKA THERAPEUTICS INC	$0	–	-115,000	–	-7.79%	–
ANTM	Exit	ANTHEM INC	$0	–	-55,200	–	-12.24%	–
MCK	Exit	MCKESSON CORP	$0	–	-68,600	–	-12.30%	–

Q3 2017

			Value		Shares		↓ Weighting
MCK	Buy	MCKESSON CORP	$10,538,000	+1.5%	68,600	+8.7%	12.30%	-5.0%
ANIK	Sell	ANIKA THERAPEUTICS INC	$6,670,000	+8.1%	115,000	-8.0%	7.79%	+1.3%
CI	New	CIGNA CORPORATION	$6,580,000	–	35,200	–	7.68%	–
CRL	Sell	CHARLES RIV LABS INTL INC	$6,569,000	-7.5%	60,812	-13.4%	7.67%	-13.4%
LGND	Sell	LIGAND PHARMACEUTICALS INC	$6,522,000	-4.4%	47,900	-14.8%	7.62%	-10.5%
PFE	Sell	PFIZER INC	$6,472,000	-5.9%	181,300	-11.5%	7.56%	-11.9%
WAT	New	WATERS CORP	$6,445,000	–	35,900	–	7.53%	–
BIIB	Sell	BIOGEN INC	$6,388,000	-5.8%	20,400	-18.4%	7.46%	-11.8%
LH	Sell	LABORATORY CORP AMER HLDGS	$6,386,000	-9.5%	42,300	-7.6%	7.46%	-15.3%
MDT	New	MEDTRONIC PLC	$6,385,000	–	82,100	–	7.46%	–
GILD	Sell	GILEAD SCIENCES INC	$6,206,000	-10.2%	76,600	-21.5%	7.25%	-15.9%
ICCC	Exit	IMMUCELL CORP	$0	–	-182,133	–	-1.66%	–
ABC	Exit	AMERISOURCEBERGEN CORP	$0	–	-109,700	–	-12.93%	–

Q2 2017

			Value		Shares		↓ Weighting
ANTM	New	ANTHEM INC	$10,385,000	–	55,200	–	12.95%	–
MCK	New	MCKESSON CORP	$10,382,000	–	63,100	–	12.95%	–
ABC	New	AMERISOURCEBERGEN CORP	$10,370,000	–	109,700	–	12.93%	–
CRL	New	CHARLES RIV LABS INTL INC	$7,102,000	–	70,212	–	8.86%	–
LH	New	LABORATORY CORP AMER HLDGS	$7,060,000	–	45,800	–	8.80%	–
GILD	New	GILEAD SCIENCES INC	$6,908,000	–	97,600	–	8.61%	–
PFE	New	PFIZER INC	$6,879,000	–	204,800	–	8.58%	–
LGND	New	LIGAND PHARMACEUTICALS INC	$6,823,000	–	56,200	–	8.51%	–
BIIB	New	BIOGEN INC	$6,784,000	–	25,000	–	8.46%	–
ANIK	New	ANIKA THERAPEUTICS INC	$6,168,000	–	125,000	–	7.69%	–
ICCC	New	IMMUCELL CORP	$1,335,000	–	182,133	–	1.66%	–

Q4 2016

			Value		Shares		↓ Weighting
SHY	Exit	ISHARES TR1-3 yr tr bd etf	$0	–	-10,000	–	-0.63%	–
BIL	Exit	SPDR SERIES TRUSTbrclys 1-3mt etf	$0	–	-20,000	–	-0.68%	–
ICCC	Exit	IMMUCELL CORP	$0	–	-168,323	–	-0.97%	–
PGNX	Exit	PROGENICS PHARMACEUTICALS IN	$0	–	-280,000	–	-1.32%	–
SUPN	Exit	SUPERNUS PHARMACEUTICALS INC	$0	–	-379,533	–	-6.98%	–
TARO	Exit	TARO PHARMACEUTICAL INDS LTD	$0	–	-85,205	–	-7.01%	–
GTS	Exit	TRIPLE-S MGMT CORPcl b	$0	–	-429,904	–	-7.02%	–
ANIK	Exit	ANIKA THERAPEUTICS INC	$0	–	-203,493	–	-7.25%	–
MRK	Exit	MERCK & CO INC	$0	–	-157,100	–	-7.30%	–
GNCIQ	Exit	GNC HLDGS INC	$0	–	-482,955	–	-7.34%	–
CRL	Exit	CHARLES RIV LABS INTL INC	$0	–	-118,612	–	-7.36%	–
INCR	Exit	INC RESH HLDGS INCcl a	$0	–	-222,875	–	-7.39%	–
ANTM	Exit	ANTHEM INC	$0	–	-135,900	–	-12.67%	–
ABC	Exit	AMERISOURCEBERGEN CORP	$0	–	-212,000	–	-12.74%	–
CAH	Exit	CARDINAL HEALTH INC	$0	–	-230,800	–	-13.34%	–

Q3 2016

			Value		Shares		↓ Weighting
CAH	Buy	CARDINAL HEALTH INC	$17,933,000	+43.7%	230,800	+44.2%	13.34%	+133.2%
ABC	Buy	AMERISOURCEBERGEN CORP	$17,125,000	+34.9%	212,000	+32.5%	12.74%	+119.0%
ANTM	Buy	ANTHEM INC	$17,030,000	+38.1%	135,900	+44.7%	12.67%	+124.1%
INCR	Sell	INC RESH HLDGS INCcl a	$9,936,000	-9.0%	222,875	-22.1%	7.39%	+47.7%
CRL	Sell	CHARLES RIV LABS INTL INC	$9,885,000	-19.9%	118,612	-20.7%	7.36%	+30.1%
GNCIQ	Sell	GNC HLDGS INC	$9,862,000	-40.5%	482,955	-29.2%	7.34%	-3.4%
MRK	Sell	MERCK & CO INC	$9,805,000	-24.1%	157,100	-29.9%	7.30%	+23.2%
ANIK	Sell	ANIKA THERAPEUTICS INC	$9,737,000	-56.0%	203,493	-50.7%	7.25%	-28.6%
GTS	Sell	TRIPLE-S MGMT CORPcl b	$9,428,000	-27.6%	429,904	-19.3%	7.02%	+17.5%
TARO	Sell	TARO PHARMACEUTICAL INDS LTD	$9,416,000	-25.0%	85,205	-1.2%	7.01%	+21.8%
SUPN	Sell	SUPERNUS PHARMACEUTICALS INC	$9,386,000	-29.9%	379,533	-42.3%	6.98%	+13.7%
PGNX	New	PROGENICS PHARMACEUTICALS IN	$1,772,000	–	280,000	–	1.32%	–
BIL	New	SPDR SERIES TRUSTbrclys 1-3mt etf	$915,000	–	20,000	–	0.68%	–
SHY	New	ISHARES TR1-3 yr tr bd etf	$850,000	–	10,000	–	0.63%	–
OSUR	Exit	ORASURE TECHNOLOGIES INC	$0	–	-475,771	–	-1.29%	–
INSYQ	Exit	INSYS THERAPEUTICS INC NEW	$0	–	-788,175	–	-4.68%	–
CXRXF	Exit	CONCORDIA INTL CORP	$0	–	-543,000	–	-5.36%	–
LPNT	Exit	LIFEPOINT HEALTH INC	$0	–	-185,851	–	-5.57%	–
FEIC	Exit	FEI CO	$0	–	-118,609	–	-5.81%	–
AMAG	Exit	AMAG PHARMACEUTICALS INC	$0	–	-671,585	–	-7.37%	–

Q2 2016

			Value		Shares		↓ Weighting
ANIK	New	ANIKA THERAPEUTICS INC	$22,135,000	–	412,588	–	10.15%	–
GNCIQ	New	GNC HLDGS INC	$16,565,000	–	681,955	–	7.60%	–
AMAG	New	AMAG PHARMACEUTICALS INC	$16,064,000	–	671,585	–	7.37%	–
SUPN	New	SUPERNUS PHARMACEUTICALS INC	$13,394,000	–	657,533	–	6.14%	–
GTS	New	TRIPLE-S MGMT CORPcl b	$13,018,000	–	532,876	–	5.97%	–
MRK	New	MERCK & CO INC	$12,910,000	–	224,100	–	5.92%	–
ABC	New	AMERISOURCEBERGEN CORP	$12,691,000	–	160,000	–	5.82%	–
FEIC	New	FEI CO	$12,677,000	–	118,609	–	5.81%	–
TARO	New	TARO PHARMACEUTICAL INDS LTD	$12,551,000	–	86,205	–	5.76%	–
CAH	New	CARDINAL HEALTH INC	$12,482,000	–	160,000	–	5.72%	–
CRL	New	CHARLES RIV LABS INTL INC	$12,334,000	–	149,612	–	5.66%	–
ANTM	New	ANTHEM INC	$12,333,000	–	93,900	–	5.66%	–
LPNT	New	LIFEPOINT HEALTH INC	$12,149,000	–	185,851	–	5.57%	–
CXRXF	New	CONCORDIA INTL CORP	$11,696,000	–	543,000	–	5.36%	–
INCR	New	INC RESH HLDGS INCcl a	$10,915,000	–	286,270	–	5.00%	–
INSYQ	New	INSYS THERAPEUTICS INC NEW	$10,199,000	–	788,175	–	4.68%	–
OSUR	New	ORASURE TECHNOLOGIES INC	$2,812,000	–	475,771	–	1.29%	–
ICCC	New	IMMUCELL CORP	$1,161,000	–	168,323	–	0.53%	–

Q4 2015

			Value		Shares		↓ Weighting
ICCC	Exit	IMMUCELL CORP	$0	–	-108,750	–	-0.38%	–
OSUR	Exit	ORASURE TECHNOLOGIES INC	$0	–	-276,603	–	-0.73%	–
ANIK	Exit	ANIKA THERAPEUTICS INC	$0	–	-40,800	–	-0.77%	–
SSRG	Exit	SYMMETRY SURGICAL INC	$0	–	-177,581	–	-0.93%	–
AIQ	Exit	ALLIANCE HEALTHCARE SRVCS IN	$0	–	-524,538	–	-3.03%	–
SUPN	Exit	SUPERNUS PHARMACEUTICALS INC	$0	–	-782,746	–	-6.50%	–
GTS	Exit	TRIPLE-S MGMT CORPcl b	$0	–	-715,981	–	-7.54%	–
VAR	Exit	VARIAN MED SYS INC	$0	–	-190,000	–	-8.29%	–
MGLN	Exit	MAGELLAN HEALTH INC	$0	–	-260,442	–	-8.54%	–
ANTM	Exit	ANTHEM INC	$0	–	-104,200	–	-8.63%	–
CRL	Exit	CHARLES RIV LABS INTL INC	$0	–	-340,320	–	-12.78%	–
LPNT	Exit	LIFEPOINT HEALTH INC	$0	–	-316,430	–	-13.27%	–
PFE	Exit	PFIZER INC	$0	–	-761,000	–	-14.14%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-249,300	–	-14.48%	–

Q3 2015

			Value		Shares		↓ Weighting
GILD	Buy	GILEAD SCIENCES INC	$24,479,000	-13.0%	249,300	+3.7%	14.48%	+0.7%
PFE	Sell	PFIZER INC	$23,903,000	-15.7%	761,000	-10.0%	14.14%	-2.4%
LPNT	Buy	LIFEPOINT HEALTH INC	$22,435,000	+23.8%	316,430	+51.8%	13.27%	+43.3%
CRL	Buy	CHARLES RIV LABS INTL INC	$21,617,000	+27.9%	340,320	+41.6%	12.78%	+48.0%
ANTM	Sell	ANTHEM INC	$14,588,000	-47.9%	104,200	-39.0%	8.63%	-39.7%
MGLN	Buy	MAGELLAN HEALTH INC	$14,436,000	-14.0%	260,442	+8.8%	8.54%	-0.4%
VAR	New	VARIAN MED SYS INC	$14,018,000	–	190,000	–	8.29%	–
GTS	Buy	TRIPLE-S MGMT CORPcl b	$12,752,000	-25.1%	715,981	+7.9%	7.54%	-13.3%
SUPN	New	SUPERNUS PHARMACEUTICALS INC	$10,982,000	–	782,746	–	6.50%	–
SSRG	Buy	SYMMETRY SURGICAL INC	$1,580,000	+59.6%	177,581	+56.5%	0.93%	+84.6%
ANIK	New	ANIKA THERAPEUTICS INC	$1,299,000	–	40,800	–	0.77%	–
OSUR	New	ORASURE TECHNOLOGIES INC	$1,228,000	–	276,603	–	0.73%	–
BASI	Exit	BIOANALYTICAL SYS INC	$0	–	-320,234	–	-0.33%	–
CRY	Exit	CRYOLIFE INC	$0	–	-90,000	–	-0.52%	–
SURG	Exit	SYNERGETICS USA INC	$0	–	-332,687	–	-0.80%	–
AET	Exit	AETNA INC NEW	$0	–	-215,900	–	-14.06%	–

Q2 2015

			Value		Shares		↓ Weighting
PFE	New	PFIZER INC	$28,366,000	–	846,000	–	14.49%	–
GILD	New	GILEAD SCIENCES INC	$28,134,000	–	240,300	–	14.37%	–
ANTM	New	ANTHEM INC	$28,019,000	–	170,700	–	14.31%	–
AET	New	AETNA INC NEW	$27,519,000	–	215,900	–	14.06%	–
LPNT	New	LIFEPOINT HEALTH INC	$18,123,000	–	208,430	–	9.26%	–
GTS	New	TRIPLE-S MGMT CORPcl b	$17,025,000	–	663,496	–	8.70%	–
CRL	New	CHARLES RIV LABS INTL INC	$16,904,000	–	240,320	–	8.64%	–
MGLN	New	MAGELLAN HEALTH INC	$16,778,000	–	239,442	–	8.57%	–
AIQ	New	ALLIANCE HEALTHCARE SRVCS IN	$9,804,000	–	524,538	–	5.01%	–
SURG	New	SYNERGETICS USA INC	$1,564,000	–	332,687	–	0.80%	–
CRY	New	CRYOLIFE INC	$1,015,000	–	90,000	–	0.52%	–
SSRG	New	SYMMETRY SURGICAL INC	$990,000	–	113,479	–	0.51%	–
ICCC	New	IMMUCELL CORP	$854,000	–	108,750	–	0.44%	–
BASI	New	BIOANALYTICAL SYS INC	$644,000	–	320,234	–	0.33%	–

Q4 2014

			Value		Shares		↓ Weighting
ICCC	Exit	IMMUCELL CORP	$0	–	-105,350	–	-0.38%	–
BASI	Exit	BIOANALYTICAL SYS INC	$0	–	-260,366	–	-0.44%	–
CRY	Exit	CRYOLIFE INC	$0	–	-438,364	–	-3.16%	–
GTS	Exit	TRIPLE-S MGMT CORPcl b	$0	–	-326,847	–	-4.74%	–
SKH	Exit	SKILLED HEALTHCARE GROUP INCcl a	$0	–	-1,094,369	–	-5.27%	–
LPNT	Exit	LIFEPOINT HOSPITALS INC	$0	–	-128,100	–	-6.46%	–
MDT	Exit	MEDTRONIC INC	$0	–	-144,600	–	-6.53%	–
MGLN	Exit	MAGELLAN HEALTH INC	$0	–	-164,792	–	-6.58%	–
CFN	Exit	CAREFUSION CORP	$0	–	-209,900	–	-6.93%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-89,300	–	-6.93%	–
CRL	Exit	CHARLES RIV LABS INTL INC	$0	–	-161,320	–	-7.03%	–
CAH	Exit	CARDINAL HEALTH INC	$0	–	-130,200	–	-7.12%	–
THOR	Exit	THORATEC CORP	$0	–	-366,066	–	-7.14%	–
AIQ	Exit	ALLIANCE HEALTHCARE SRVCS IN	$0	–	-529,818	–	-8.74%	–
V107SC	Exit	WELLPOINT INC	$0	–	-129,200	–	-11.27%	–
AET	Exit	AETNA INC NEW	$0	–	-190,900	–	-11.28%	–

Q3 2014

			Value		Shares		↓ Weighting
AET	Buy	AETNA INC NEW	$15,463,000	+45.1%	190,900	+45.3%	11.28%	+88.0%
V107SC	Sell	WELLPOINT INC	$15,455,000	-1.5%	129,200	-11.4%	11.27%	+27.6%
AIQ	Buy	ALLIANCE HEALTHCARE SRVCS IN	$11,979,000	-9.5%	529,818	+8.0%	8.74%	+17.2%
THOR	Sell	THORATEC CORP	$9,785,000	-36.3%	366,066	-16.9%	7.14%	-17.4%
CAH	Sell	CARDINAL HEALTH INC	$9,755,000	+4.8%	130,200	-4.1%	7.12%	+35.8%
CRL	Sell	CHARLES RIV LABS INTL INC	$9,637,000	-35.2%	161,320	-42.0%	7.03%	-16.1%
GILD	Sell	GILEAD SCIENCES INC	$9,506,000	-3.2%	89,300	-24.6%	6.93%	+25.3%
CFN	Sell	CAREFUSION CORP	$9,498,000	-2.5%	209,900	-4.4%	6.93%	+26.3%
MGLN	Sell	MAGELLAN HEALTH INC	$9,019,000	-40.2%	164,792	-32.0%	6.58%	-22.5%
MDT	Sell	MEDTRONIC INC	$8,958,000	-12.1%	144,600	-9.6%	6.53%	+13.8%
LPNT	Sell	LIFEPOINT HOSPITALS INC	$8,863,000	-14.1%	128,100	-22.9%	6.46%	+11.3%
SKH	Sell	SKILLED HEALTHCARE GROUP INCcl a	$7,223,000	+3.2%	1,094,369	-1.7%	5.27%	+33.7%
GTS	Sell	TRIPLE-S MGMT CORPcl b	$6,504,000	+2.3%	326,847	-7.8%	4.74%	+32.5%
CRY	Buy	CRYOLIFE INC	$4,327,000	+16.9%	438,364	+6.0%	3.16%	+51.5%
BASI	Buy	BIOANALYTICAL SYS INC	$601,000	+53.3%	260,366	+67.9%	0.44%	+98.2%
ICCC	Buy	IMMUCELL CORP	$524,000	+51.9%	105,350	+34.2%	0.38%	+96.9%
ESRX	Exit	Express Scripts Hldg Co	$0	–	-107,500	–	-4.20%	–
HOLX	Exit	Hologic Inc	$0	–	-321,920	–	-4.60%	–
HRC	Exit	Hill Rom Hldgs Inc	$0	–	-239,200	–	-5.59%	–

Q2 2014

			Value		Shares		↓ Weighting
V107SC	New	WellPoint Inc	$15,690,000	–	145,800	–	8.83%	–
THOR	New	Thoratec Corp	$15,351,000	–	440,366	–	8.64%	–
MGLN	New	Magellan Health Inc	$15,074,000	–	242,192	–	8.49%	–
CRL	New	Charles Riv Labs Intl Inc	$14,879,000	–	278,013	–	8.38%	–
AIQ	New	Alliance HealthCare Srvcs In	$13,240,000	–	490,378	–	7.46%	–
AET	New	Aetna Inc New	$10,654,000	–	131,400	–	6.00%	–
LPNT	New	LifePoint Hospitals Inc	$10,315,000	–	166,100	–	5.81%	–
MDT	New	Medtronic Inc	$10,195,000	–	159,900	–	5.74%	–
HRC	New	Hill Rom Hldgs Inc	$9,929,000	–	239,200	–	5.59%	–
GILD	New	Gilead Sciences Inc	$9,825,000	–	118,500	–	5.53%	–
CFN	New	CareFusion Corp	$9,739,000	–	219,600	–	5.48%	–
CAH	New	Cardinal Health Inc	$9,304,000	–	135,700	–	5.24%	–
HOLX	New	Hologic Inc	$8,161,000	–	321,920	–	4.60%	–
ESRX	New	Express Scripts Hldg Co	$7,453,000	–	107,500	–	4.20%	–
SKH	New	Skilled Healthcare Group Inccl a	$7,000,000	–	1,112,885	–	3.94%	–
GTS	New	Triple-S Mgmt Corpcl b	$6,359,000	–	354,675	–	3.58%	–
CRY	New	CryoLife Inc	$3,700,000	–	413,364	–	2.08%	–
BASI	New	Bioanalytical Sys Inc	$392,000	–	155,097	–	0.22%	–
ICCC	New	ImmuCell Corp	$345,000	–	78,477	–	0.19%	–

Compare quarters

Export HealthInvest Partners AB's holdings